MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables. The company is headquartered in Hangzhou, Zhejiang and currently employs 645 full-time employees. The company went IPO on 2021-10-19. The firm's main business is engaged in the manufacture and sale of blood glucose monitoring system (BGMS), continuous glucose monitoring system (CGMS) and insulin pump systems. The firm has the portfolio of products in the field of diabetes monitoring, treatment and management, covering patch insulin pump system, CGMS, closed-loop artificial pancreas system, BGMS products, as well as diabetes digital management software. The firm conducts its businesses in the domestic and overseas markets.
02235.HK stock price ended at $7.26 on Jueves, after rising 0.41%
On the latest trading day Feb 12, 2026, the stock price of 02235.HK rose by 0.41%, climbing from $7.23 to $7.26. During the session, the stock saw a volatility of 2.90%, with prices oscillating between a daily low of $7.23 and a high of $7.44. Notably, trading volume dropped by 71.6K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 202.5K shares were traded, equating to a market value of approximately $1.2B.
Señales Técnicas de 02235.HK
Resumen de Señales Técnicas
Señales de compra 2
Señales Neutras 1
Señales de venta 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
02235.HK actualmente presenta 2 señales de compra y 4 señales de venta. La acción ha estado en una tendencia alcista desde 12:00 AM, con un cambio total en el precio de 0.41% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Sell para el mediano plazo.
Señales alcistas/bajistas para 02235.HK
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para 02235.HK. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.